Skip to content

Investigating intestinal immune disorders in psoriasis

Investigating intestinal immune disorders in psoriasis - Intestinal immune disorders in psoriasis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000042863
Enrollment
50
Registered
2020-12-28
Start date
2020-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease, psoriasis

Interventions

None listed

Sponsors

Akita University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Psoriasis patients being treated in Akita University Hospital Performance Status 0 Persons who agreed to attend the study and filled the consent form

Exclusion criteria

Exclusion criteria: Persons with severe comobidities or uncontrolled mental disorders Persons who did not agree to attend the study Persons who are not suitable for this study.

Design outcomes

Primary

MeasureTime frame
intestinal microbiota, RNA expression in intestinal mucosa, inflammatory marker in feces

Countries

Japan

Contacts

Public ContactYosuke Shimodaira

Akita University Graduate School of Medicine Gastroenterology and Neurology

yosuke.shimodaira@med.akita-u.ac.jp018-884-6104

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026